Midkine promotes perineural invasion in human pancreatic cancer

World Journal of Gastroenterology

Volumn 20, Issue 11, 2014, Pages 3018-3024

  Yao, Jun ^a   Li, Wen Yao ^a   Li, Shuo Guo ^a   Feng, Xiao Shan ^a   Gao, She Gan ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Midkine; Neurite growth; Pancreatic cancer; Perineural invasion; Syndecan 3

Indexed keywords

MIDKINE; SYNDECAN 3; MDK PROTEIN, HUMAN; NERVE GROWTH FACTOR; SDC3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PERINEURAL INVASION; PROTEIN EXPRESSION; SURVIVAL RATE; TUMOR VOLUME; VERY ELDERLY; CASE CONTROL STUDY; CHINA; EPIDEMIOLOGY; INNERVATION; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; PANCREAS; PANCREATIC NEOPLASMS; SYNDECAN-3;

EID: 84896479887     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i11.3018     Document Type: Article

References (36)

1. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004; 363: 1049-1057 [PMID: 15051286 DOI: 10.1016/S0140-6736(04)15841-8]
2. Laheru D, Jaffee EM. Immunotherapy for pancreatic cancer-science driving clinical progress. Nat Rev Cancer 2005; 5: 459-467 [PMID: 15905855 DOI: 10.1038/nrc1630]
3. Ceyhan GO, Giese NA, Erkan M, Kerscher AG, Wente MN, Giese T, Büchler MW, Friess H. The neurotrophic factor artemin promotes pancreatic cancer invasion. Ann Surg 2006; 244: 274-281 [PMID: 16858191 DOI: 10.1097/01.sla.0000217642.68697.55]
4. Veit C, Genze F, Menke A, Hoeffert S, Gress TM, Gierschik P, Giehl K. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res 2004; 64: 5291-5300 [PMID: 15289335 DOI: 10.1158/0008-5472.CAN-04-1112]
5. Tomomura M, Kadomatsu K, Matsubara S, Muramatsu T. A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem 1990; 265: 10765-10770 [PMID: 2355021]
6. Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 2002; 132: 359-371 [PMID: 12204104 DOI: 10.1093/oxfordjournals.jbchem.a003231]
7. Rauvala H, Peng HB. HB-GAM (heparin-binding growth-associated molecule) and heparin-type glycans in the development and plasticity of neuron-target contacts. Prog Neurobiol 1997; 52: 127-144 [PMID: 9185236 DOI: 10.1016/S0301-0082(97)00007-5]
8. Kurosawa N, Chen GY, Kadomatsu K, Ikematsu S, Sakuma S, Muramatsu T. Glypican-2 binds to midkine: the role of glypican-2 in neuronal cell adhesion and neurite outgrowth. Glycoconj J 2001; 18: 499-507 [PMID: 12084985]
9. Sakaguchi N, Muramatsu H, Ichihara-Tanaka K, Maeda N, Noda M, Yamamoto T, Michikawa M, Ikematsu S, Sakuma S, Muramatsu T. Receptor-type protein tyrosine phosphatase zeta as a component of the signaling receptor complex for midkine-dependent survival of embryonic neurons. Neurosci Res 2003; 45: 219-224 [PMID: 12573468 DOI: 10.1016/S0168-0102(02)00226-2]
10. Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T, Michikawa M. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 1999; 73: 2084-2092 [PMID: 10537068]
11. Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett 2004; 204: 127-143 [PMID: 15013213 DOI: 10.1016/S0304-3835(03)00450-6]
12. Maeda S, Shinchi H, Kurahara H, Mataki Y, Noma H, Maemura K, Aridome K, Yokomine T, Natsugoe S, Aikou T, Takao S. Clinical significance of midkine expression in pancreatic head carcinoma. Br J Cancer 2007; 97: 405-411 [PMID: 17622248 DOI: 10.1038/sj.bjc.6603879]
13. Kinnunen A, Kinnunen T, Kaksonen M, Nolo R, Panula P, Rauvala H. N-syndecan and HB-GAM (heparin-binding growth-associated molecule) associate with early axonal tracts in the rat brain. Eur J Neurosci 1998; 10: 635-648 [PMID: 9749725 DOI: 10.1046/j.1460-9568.1998.00082.x]
14. Raulo E, Chernousov MA, Carey DJ, Nolo R, Rauvala H. Isolation of a neuronal cell surface receptor of heparin binding growth-associated molecule (HB-GAM). Identification as N-syndecan (syndecan-3). J Biol Chem 1994; 269: 12999-13004 [PMID: 8175719]
15. Kinnunen T, Kaksonen M, Saarinen J, Kalkkinen N, Peng HB, Rauvala H. Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J Biol Chem 1998; 273: 10702-10708 [PMID: 9553134 DOI: 10.1074/jbc.273.17.10702]
16. Ohhashi S, Ohuchida K, Mizumoto K, Egami T, Yu J, Cui L, Toma H, Takahata S, Nabae T, Tanaka M. Midkine mRNA is overexpressed in pancreatic cancer. Dig Dis Sci 2009; 54: 811-815 [PMID: 18712601 DOI: 10.1007/s10620-008-0434-4]
17. Ibusuki M, Fujimori H, Yamamoto Y, Ota K, Ueda M, Shinriki S, Taketomi M, Sakuma S, Shinohara M, Iwase H, Ando Y. Midkine in plasma as a novel breast cancer marker. Cancer Sci 2009; 100: 1735-1739 [PMID: 19538527 DOI: 10.1111/j.1349-7006.2009.01233.x]
18. Nordin A, Wang W, Welén K, Damber JE. Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer. Prostate 2013; 73: 657-667 [PMID: 23129424 DOI: 10.1002/pros.22607]
19. Ikematsu S, Nakagawara A, Nakamura Y, Ohira M, Shinjo M, Kishida S, Kadomatsu K. Plasma midkine level is a prognostic factor for human neuroblastoma. Cancer Sci 2008; 99: 2070-2074 [PMID: 19016768 DOI: 10.1111/j.1349-7006.2008.00957.x]
20. Kishida S, Mu P, Miyakawa S, Fujiwara M, Abe T, Sakamoto K, Onishi A, Nakamura Y, Kadomatsu K. Midkine promotes neuroblastoma through Notch2 signaling. Cancer Res 2013; 73: 1318-1327 [PMID: 23243020]
21. Yao J, Zhang M, Ma QY, Wang Z, Wang LC, Zhang D. PAd-shRNA-PTN reduces pleiotrophin of pancreatic cancer cells and inhibits neurite outgrowth of DRG. World J Gastroenterol 2011; 17: 2667-2673 [PMID: 21677838 DOI: 10.3748/wjg.v17.i21.2667]
22. Yao J, Ma Q, Wang L, Zhang M. Pleiotrophin expression in human pancreatic cancer and its correlation with clinicopathological features, perineural invasion, and prognosis. Dig Dis Sci 2009; 54: 895-901 [PMID: 18716876 DOI: 10.1007/s10620-008-0433-5]
23. Zhu Z, Friess H, diMola FF, Zimmermann A, Graber HU, Korc M, Büchler MW. Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J Clin Oncol 1999; 17: 2419-2428 [PMID: 10561305]
24. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumor classification revisited. Cancer 2002; 94: 2511-2516 [PMID: 12015777 DOI: 10.1002/cncr.10492]
25. Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer 2009; 115: 3379-3391 [PMID: 19484787 DOI: 10.1002/cncr.24396]
26. Bapat AA, Hostetter G, Von Hoff DD, Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer 2011; 11: 695-707 [PMID: 21941281]
27. Ceyhan GO, Demir IE, Altintas B, Rauch U, Thiel G, Müller MW, Giese NA, Friess H, Schäfer KH. Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells. Biochem Biophys Res Commun 2008; 374: 442-447 [PMID: 18640096 DOI: 10.1016/j.bbrc.2008.07.035]
28. Gil Z, Cavel O, Kelly K, Brader P, Rein A, Gao SP, Carlson DL, Shah JP, Fong Y, Wong RJ. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst 2010; 102: 107-118 [PMID: 20068194 DOI: 10.1093/jnci/djp456]
29. Ma J, Jiang Y, Jiang Y, Sun Y, Zhao X. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer. J Gastroenterol Hepatol 2008; 23: 1852-1859 [PMID: 19120874 DOI: 10.1111/j.1440-1746.2008.05579.x]
30. Marchesi F, Piemonti L, Fedele G, Destro A, Roncalli M, Albarello L, Doglioni C, Anselmo A, Doni A, Bianchi P, Laghi L, Malesci A, Cervo L, Malosio M, Reni M, Zerbi A, Di Carlo V, Mantovani A, Allavena P. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma. Cancer Res 2008; 68: 9060-9069 [PMID: 18974152 DOI: 10.1158/0008-5472.CAN-08-1810]
31. Ceyhan GO, Schäfer KH, Kerscher AG, Rauch U, Demir IE, Kadihasanoglu M, Böhm C, Müller MW, Büchler MW, Giese NA, Erkan M, Friess H. Nerve growth factor and artemin are paracrine mediators of pancreatic neuropathy in pancreatic adenocarcinoma. Ann Surg 2010; 251: 923-931 [PMID: 20395845 DOI: 10.1097/SLA.0b013e3181d974d4]
32. Hirai I, Kimura W, Ozawa K, Kudo S, Suto K, Kuzu H, Fuse A. Perineural invasion in pancreatic cancer. Pancreas 2002; 24: 15-25 [PMID: 11741178 DOI: 10.1097/00006676-200201000-00003]
33. Yi SQ, Miwa K, Ohta T, Kayahara M, Kitagawa H, Tanaka A, Shimokawa T, Akita K, Tanaka S. Innervation of the pancreas from the perspective of perineural invasion of pancreatic cancer. Pancreas 2003; 27: 225-229 [PMID: 14508126 DOI: 10.1097/00006676-200310000-00005]
34. Kinnunen T, Raulo E, Nolo R, Maccarana M, Lindahl U, Rauvala H. Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem 1996; 271: 2243-2248 [PMID: 8567685 DOI: 10.1074/jbc.271.4.2243]
35. Nolo R, Kaksonen M, Raulo E, Rauvala H. Co-expression of heparin-binding growth-associated molecule (HB-GAM) and N-syndecan (syndecan-3) in developing rat brain. Neurosci Lett 1995; 191: 39-42 [PMID: 7659286 DOI: 10.1016/0304-3940(94)11551-1]
36. Mitsunaga S, Hasebe T, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Nakagohri T, Ochiai A. Detail histologic analysis of nerve plexus invasion in invasive ductal carcinoma of the pancreas and its prognostic impact. Am J Surg Pathol 2007; 31: 1636-1644 [PMID: 18059219 DOI: 10.1097/PAS.0b013e318065bfe6]